|
Volumn 3, Issue 4, 2000, Pages 193-197
|
Testing for hereditary risk of breast and ovarian cancer
a
Utah
(United States)
|
Author keywords
BRCA1; BRCA2; Breast cancer; Genetic testing; Hereditary cancer; Ovarian cancer
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TAMOXIFEN;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RISK;
CASE CONTROL STUDY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC TEST;
FAMILIAL CANCER;
FAMILY HISTORY;
FEMALE;
GENE MUTATION;
GENETIC ANALYSIS;
GENETIC SCREENING;
GENETIC SUSCEPTIBILITY;
HUMAN;
MASTECTOMY;
OVARY CANCER;
PRIORITY JOURNAL;
RISK ASSESSMENT;
|
EID: 0034442187
PISSN: 14222795
EISSN: None
Source Type: Journal
DOI: 10.1159/000051138 Document Type: Conference Paper |
Times cited : (1)
|
References (30)
|